Laserfiche WebLink
FINAL <br />7/14/2017 <br />responsibilities under this Agreement, including the maintenance responsibilities under this <br />Section. <br />2.1 Ownership of the Facility. The ownership of the Facility shall remain with the <br />City, who is the holder of the NPDES MS4 permit covering this Facility. <br />2.2 General Operations and Maintenance Responsibilities. The City shall be <br />responsible for ongoing general operations and maintenance of the Facility once it is completed. <br />The MWMO shall perform select operation and maintenance activities as described below. At all <br />times, the City shall be solely responsible for maintenance of the Physical Structure. <br />2.3 Operations and Maintenance during Start -up and Initial Research Phase. <br />The MWMO will perform operations and maintenance of the Primary Treatment Components, <br />Secondary Treatment Components and Additional Treatment Components during the start-up <br />and initial research phases. Operations and maintenance will be performed in reasonable <br />accordance with the O &M Plan (attached as Exhibit B). The MWMO will keep the City <br />informed of its findings and actions, related to operations and maintenance, during this time. For <br />the purposes of this Agreement, the start-up and initial research phase shall run from the <br />completion of the Facility until December 31, 2020. <br />2.4 Operations and Maintenance following the Start-up and Initial Research <br />Phase. Following the start-up and initial research phases, as defined in Section 2.3, the City shall <br />be solely responsible for the operations and maintenance of the Primary Treatment Components. <br />The MWMO shall continue performing operations and maintenance of the Secondary Treatment <br />Components and Additional Treatment Components. Again, operations and maintenance will be <br />performed in accordance with the O &M Plan (attached as Exhibit B). Should the MWMO <br />choose to suspend research in the Secondary Treatment Site, the City will remain responsible for <br />operations and maintenance of the Primary Treatment Components and the Physical Structure. <br />The City will take over operations and maintenance of the Additional Components. Should the <br />MWMO subsequently choose to reinstate research in the Secondary Treatment Site (in <br />accordance with Section 2.6), they will resume performing operations and maintenance of the <br />Secondary Treatment Components and Additional Treatment Components. <br />2.5 Inspections. During the start-up and initial research phases, the City will take <br />part in the inspections of the Facility and observe all maintenance activities. Following the start- <br />up and initial research phases, the MWMO shall be allowed an opportunity to take part in the <br />Primary Treatment Component inspections to gather data as it deems necessary in reasonable <br />accordance with the O &M Plan. The MWMO may also access the properties on which the <br />Facility is located as needed to place, maintain, and read its monitoring equipment. <br />2.6 Secondary Treatment Site Treatment Technology. The MWMO may, at its <br />own cost and as it determines it appropriate, install and operate different technologies in the <br />Secondary Treatment Component to improve treatment at the Facility. The MWMO agrees to <br />present any proposed changes to the City at least 60 days prior to initiating any such work. The <br />City agrees to work cooperatively with the MWMO as needed to facilitate the installation of the <br />new treatment technology by the MWMO. <br />